Financial Statements 2Q26

June 30, 2026

with Independent Auditor's Review Report

Contents

Independent auditor's review report on interim financial information 1

Interim financial information

Statements of financial position 3

Statements of profit or loss 5

Statements of comprehensive income 6

Statements of changes in equity 7

Statements of cash flows 8

Statements of value added 9

Notes to the interim financial information 10

Centro Empresarial PB 370

Praia de Botafogo, 370

8º ao 10º andar - Botafogo

22250-040 - Rio de Janeiro - RJ - Brazil

Phone: +55 21 3263-7000

ey.com.br

A free translation from Portuguese into English of Independent Auditor's Review Report on interim financial information prepared in Brazilian currency in accordance with CPC 21 (R1) and IAS 34 - Interim Financial Reporting and the rules issued by the Brazilian Securities and Exchange Commission (CVM) applicable to the preparation of Quarterly Information (ITR)

To the Shareholders, Board of Directors and Officers of

Rio de Janeiro - RJ, Brazil

We have reviewed the individual and consolidated interim financial information of Rede D'Or São Luiz

S.A. (the "Company") contained in the Quarterly Information Form (ITR) for the quarter ended June 30, 2026, which comprises the statement of financial position as at June 30, 2026, and the statements of profit or loss and of comprehensive income for the three and six-month periods then ended, and the statements of changes in equity and of cash flows for the six-month period then ended, including explanatory information.

The executive board is responsible for the preparation of the individual and consolidated interim financial information in accordance with Accounting Pronouncement CPC 21 (R1) - Interim Financial Reporting, and with International Accounting Standard (IAS) 34 - Interim Financial Reporting (IFRS Accounting Standards), issued by the International Accounting Standards Board (IASB), as well as for the fair presentation of this information in accordance with the rules issued by the Brazilian Securities and Exchange Commission (CVM) applicable to the preparation of the Quarterly Information (ITR).

Our responsibility is to express a conclusion on this interim financial information based on our review.

We conducted our review in accordance with the Brazilian and International Standards on Review Engagements (NBC TR 2410 and ISRE 2410 - Review of Interim Financial Information Performed by the Independent Auditor of the Entity). A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with auditing standards and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Based on our review, nothing has come to our attention that causes us to believe that the accompanying individual and consolidated interim financial information included in the quarterly information is not prepared, in all material respects, in accordance with Accounting Pronouncement CPC 21 (R1) and IAS 34 applicable to the preparation of Quarterly Information (ITR), and presented consistently with the rules issued by the Brazilian Securities and Exchange Commission (CVM).

1

A member firm of Ernst & Young Global Limited

The quarterly information referred to above includes the individual and consolidated statements of value added (SVA) for the six-month period ended June 30, 2026, prepared under the responsibility of the Company's executive board and presented as supplementary information for purposes of IAS 34. These statements have been subject to the same review procedures performed together with quarterly information review, in order to conclude whether they have been reconciled to the interim financial information and accounting records, as applicable, and whether their form and content are in accordance the criteria defined in Accounting Pronouncement CPC 09 - Statement of Value Added.

Based on our review, nothing has come to our attention that causes us to believe that they were not prepared, in all material respects, in accordance with the criteria set forth by this Standard and consistently with the individual and consolidated interim financial information taken as a whole.

Rio de Janeiro, August 11, 2026. ERNST & YOUNG

Auditores Independentes S/S Ltda.

CRC SP-015199/F

Wilson J.O. Moraes Accountant CRC RJ-107211/O

A free translation from Portuguese into English of Interim Financial Information prepared in Brazilian currency in accordance with CPC 21 (R1) and IAS 34 - Interim Financial Reporting and the rules issued by the Brazilian

Securities and Exchange Commission (CVM) applicable to the preparation of Quarterly Information (ITR)

Statements of financial position

June 30, 2026 and December 31, 2025 (In thousands of reais)

Individual Consolidated

Total assets 77,188,394 70,795,084 113,232,658 106,548,532

Statements of financial position

June 30, 2026 and December 31, 2025 (In thousands of reais)

Statements of profit or loss

Six-month periods ended June 30, 2026 and 2025 (In thousands of reais, unless otherwise stated)

Statements of comprehensive income

Six-month periods ended June 30, 2026 and 2025 (In thousands of reais)

Statements of changes in equity

Six-month periods ended June 30, 2026 and 2025 (In thousands of reais)

Attributable to the Company's controlling shareholders

Capital Capital reserves Income reserves Premium

reserve

Goodwill in Share-based

Other

Future

Share issue

(share

capital

payment

Treasury

Legal

Res erve

comprehensiv

capital

Retained

Noncontrolling

Net finance income (costs) from insurance and

Net finance income (costs) from insurance and

See accompanying notes.

Statements of cash flows

Six-month periods ended June 30, 2026 and 2025 (In thousands of reais)

Individual Consolidated

See accompanying notes.

Statements of value added

Six-month periods ended June 30, 2026 and 2025 (In thousands of reais, unless otherwise stated)

Notes to the interim financial information June 30, 2026

(In thousands of reais, unless otherwise stated)

1. Operations

   Rede D'Or São Luiz S.A. (the "Company" or "Parent Company" and jointly with its subsidiaries "Rede D'Or" or "Group"), headquartered at Rua Francisco Marengo, 1.312, in the city and state of São Paulo, is engaged in the rendering of hospital services, offering assistance and hospitality concepts, creating medical and diagnostic excellence centers and generating medical knowledge and experience that ensure security to customers, either doctors, patients or healthcare plans. Through its subsidiaries and associates, the Company operates in the health (health and dental insurance, administrative services only (ASO) health and dental plans, and health and wellness solutions), life insurance, private pension, and asset management segments.

   Rede D'Or operates in the states of Rio de Janeiro, São Paulo, Pernambuco, Maranhão, Bahia, Sergipe, Paraná, Ceará, Minas Gerais, Mato Grosso do Sul, Paraíba, Alagoas, Pará and the Federal District, with 73 own hospitals in operation and over 20 projects under development, in addition to oncology and radiotherapy clinics and laboratories. Currently, the Group has 10,596 hospital beds in total.

   The first hospital unit, Hospital Barra D'Or, was opened in 1998, and Hospital Copa D'Or and Hospital Quinta D'Or were opened in 2000 and 2001, respectively. Since 2004, strategic partnerships have been made with other hospitals, thus increasing its range of expertise and reaching other areas in Rio de Janeiro. Also through partnerships and acquisitions, Rede D'Or started operations in the state of Pernambuco in 2007; in the states of Maranhão and Bahia in 2018; in the state of Sergipe in 2019; in the states of Paraná and Ceará in 2020; in the states of Minas Gerais, Mato Grosso do Sul and Paraíba in 2021; and in the state of Alagoas in 2022.

   In December 2022, the business combination between the Company and Sul América S.A. was completed through the merger of Sul América S.A. into Rede D'Or. As a result of the merger, Sul América S.A. was dissolved and succeeded by Rede D'Or as regards all its assets, rights and obligations, and Rede D'Or became the parent company of Sul América Group ("SASA" or "Sul América" - comprising the subsidiaries, associates and investment funds remaining from the merger of Sul América S.A.).

   Seasonality

   There are no significant seasonal effects on the Company's operations; however, a smaller volume of customers and, consequently, of claims in the insurance and health insurance businesses, is generally observed in December, January and February due to year-end celebrations and vacation period, and a larger volume of customers is observed in winter.

   Notes to the interim financial information (Continued)

   June 30, 2026

   (In thousands of reais, unless otherwise stated)

2. Accounting policies

   This individual and consolidated interim financial information was prepared in accordance with Accounting Pronouncement CPC 21 (R1) - Interim Financial Reporting, issued by the Brazilian Accounting Pronouncements Committee ("CPC"), and in accordance with IAS 34 - Interim Financial Reporting, issued by the International Accounting Standards Board (IASB), and is presented in accordance with the rules issued by the Brazilian Securities and Exchange Commission ("CVM") applicable to the preparation of Quarterly Information (ITR). The statements of value added are presented as supplementary information for IFRS purposes.

   The accounting policies as well as estimates and critical accounting judgments adopted by the Group in this interim financial information are consistent with those adopted in the financial statements for the year ended December 31, 2025, disclosed on February 25, 2026.

   P&L for the six-month period ended June 30, 2026 does not necessarily indicate the P&L expected for the entire year ending December 31, 2026. The interim financial information and related notes do not include all information and disclosures required for the annual financial statements. As such, this interim financial information must be read together with the audited annual financial statements as of December 31, 2025.

   Authorization to complete the preparation of this interim financial information was provided by Company management on August 11, 2026.

   The individual and consolidated interim financial information includes the operations of the Company and its subsidiaries, as presented in Note 8. Additionally, as of June 30, 2026, the Company holds investments in funds-of-one that are fully consolidated.

3. Atlântica Hospitais transaction

On August 16, 2024, the Company entered into a partnership with Atlântica Hospitais e Participações S.A. ("Atlântica Hospitais") - a company focused on hospital investments, indirectly controlled by Bradseg Participações S.A., which in turn is the parent of Bradesco Seguros Group - for the creation of the new hospital network "Atlântica D'Or" (Pacífico Holding Imobiliária Hospitalar S.A. and Pacífico Operações Hospitalares S.A.). The Partnership was established as a corporate association aimed at making investments, constructing, developing, and operating hospitals, with a share of 50,01% for Rede D'Or, which will serve as the hospital operator and controller of the new Atlântica D'Or hospital network, and 49,99% for Atlântica Hospitais. This partnership encompasses all investments and assets, including real estate, related to the hospitals.

Notes to the interim financial information (Continued)

June 30, 2026

(In thousands of reais, unless otherwise stated)

1. Atlântica Hospitais transaction (Continued)

   On September 1, 2025, the Company entered into an Investment, Purchase and Sale Agreement and Other Covenants with Atlântica Hospitais, for the purpose of contributing the assets and liabilities of Hospital Glória D'Or and SPE IH Glória D'Or, in the city of Rio de Janeiro, to the Atlântica D'Or hospital network, with ownership stakes of 50,01% by Rede D'Or and 49,99% by Atlântica Hospitais. On January 30, 2026, the Company completed the contribution of the assets and liabilities of Hospital Glória D'Or and SPE IH Glória D'Or to Atlântica D'Or. The Company received R$452,037 from Bradesco Seguros in connection with the acquisition of the shares corresponding to a 49.99% equity interest.

   On November 10, 2025 the Company entered into an Investment, Purchase and Sale Agreement and Other Covenants with Atlântica Hospitais, for the purpose of contributing the hospital operations of Maternidade São Luiz Star ("Maternidade Star"), in the city of São Paulo, to the Atlântica D'Or hospital network, with ownership stakes of 50.01% by Rede D'Or and 49.99% by Atlântica Hospitais. The transaction does not include the real property in which Maternidade Star's activities are conducted, which will continue to be fully owned by Rede D'Or. On February 26, 2026, the Company completed the closing of the contribution of the assets and liabilities of Maternidade Star to Atlântica D'Or. The Company received R$224,326 from Bradesco Seguros in connection with the acquisition of the shares corresponding to a 49.99% equity interest.

   On May 26, 2026, the Company entered into an Investment, Purchase and Sale Agreement and Other Covenants with Atlântica Hospitais and Atlântica Empreendimentos Imobiliários Ltda. ("Atlântica"), for the purpose of contributing real properties located in the São Conrado neighborhood, in the city and state of Rio de Janeiro, where the São Conrado D'Or Hospital will be constructed, developed, and operated in the future, to the Atlântica D'Or hospital network, with ownership stakes 50.01% by Rede D'Or, and 49.99% by Atlântica. On July 13, 2026, the Company completed the closing of the contribution of certain properties owned by Rede D'Or to Atlântica D'Or. The consideration amounting to R$60,582, relating to the acquisition of 49.99% of the shares, will be fully settled by January 2027.

   As of June 30, 2026, the partnership encompasses six hospitals in operation (São Luiz Guarulhos, São Luiz Alphaville, Macaé D'Or, Hospital São Luiz Campinas, Hospital Glória D'Or and Maternidade São Luiz Star) and two other projects under development (located in Taubaté and Ribeirão Preto).

2. Cash and cash equivalents and securities
   1. Cash and cash equivalents

      Individual Consolidated

      	06/30/2026	12/31/2025	06/30/2026	12/31/2025
      Cash and cash equivalents
      Cash and banks	14,708	13,626	84,637	63,526
      Marketable securities	497,127	200,537	2,930,280	3,641,889
      Cash and cash equivalents	511,835	214,163	3,014,917	3,705,415

      Marketable securities classified as cash equivalents have maturities of less than three months from the date of acquisition and have an insignificant risk of changes in value.

   2. Securities

      Marketable securities are broken down in the table below, which shows their respective classifications, curve value and market value, as well as the contractual average rates:

      Fair value through Individual

      profit or loss Amortized cost

      Market value/ Description carrying amount		Curve value/carrying amount	Market value	Average interest rate (a)	Total 06/30/2026	Average interest rate (a)	Total 12/31/2026
      Fixed income securities - corporate bonds	9,268,594				9,650,589		7,105,528
      Bank deposit certificates Floating rate CDI %	9,131,927	-	- 101.11% CDI		9,131,927	101.68% CDI	6,965,003
      Debentures
      Floating rate CDI + Financial bills	-	381,995	381,995	CDI+4.00% p.a.	381,995	-	-
      Floating rate CDI +	136,667	-	- CDI+0.24% p.a.		136,667	CDI+0.27% p.a.	84,556
      Floating rate CDI % Fixed income securities - government securities	- 1,423,423	-	- -		- 1,423,423	105.00% CDI	55,969 1,304,929
      Financial treasury bills	1,423,423	-	- SELIC		1,423,423	SELIC	1,304,929
      Investment fund shares Investment fund shares - other than	151,973				151,973		26
      funds-of-one	151,973	-	- -		151,973	-	26
      					11,225,985		8,410,483
      			Current		10,843,990	Current	8,410,483
      			Noncurrent		381,995	Noncurrent	-

      4. Cash and cash equivalents and securities (Continued) 4.2. Securities (Continued)

      Fair value through profit or loss

      Market value/

      Fair value through other

      comprehensive income Amortized cost

      Market

      value/ Curve

      Consolidated

      06/30/2026 Average rate 12/31/2025

      Description carrying amount Curve value			Carrying amount	value/carrying amount	Market value	Average interest rate (a)	Total	interest (a)	Total
      Fixed income securities - corporate bonds 14,440,578 1,009,416			971,245	381,995	381,995		15,793,818		14,199,719
      Bank deposit certificates Floating rate CDI +	5,099	-	-	-	-	CDI+0.27% p.a.	5,099	CDI+0.26% p.a.	19,721
      Floating rate CDI % Debentures	10,727,647	127,901	127,901	-	-	101.59% CDI	10,855,548	101.69% CDI	9,715,947
      Fixed rate	75,477	-	-	-	-	13.79% p.a.	75,477	12.79% p.a.	73,366
      Floating rate CDI +	984,738	93,967	95,895	381,995	381,995	CDI+2.09% p.a.	1,462,628	CDI+1.72% p.a.	1,204,552
      Floating rate CDI %	18,942	-	-	-	-	106.23% CDI	18,942	116.96% CDI	3,237
      Floating rate IPCA	700,937	-	-	-	-	IPCA+8.16% p.a.	700,937	IPCA+7.29% p.a.	580,135
      Floating rate IGP-M Financial bills	-	111,703	99,127	-	-	IGPM+5.84% p.a.	99,127	IGPM+5.84% p.a.	95,522
      Fixed rate	9,070	-	-	-	-	14.89% fixed rate	9,070	-	-
      Floating rate CDI +	1,761,306	-	-	-	-	CDI+0.37% p.a.	1,761,306	CDI+0.47% p.a.	1,683,459
      Floating rate CDI %	74,330	-	-	-	-	104.62%CDIt	74,330	108.99%CDI	116,001
      Floating rate IPCA	-	644,264	616,350	-	-	IPCA+8.17% p.a.	616,350	IPCA+8.17% p.a.	610,887
      Promissory notes	6,472	31,581	31,972	-	-	CDI+1.57% p.a.	38,444	CDI+1.54% p.a.	40,872
      Mortgage-backed Securities ("CRI") CRI Fixed rate	10,594	-	-	-	-	15,54% p.a.	10,594	15.86% p.a.	1,213
      Floating rate CDI +	6,968	-	-	-	-	1.74% p.a.	6,968	-	-
      Time deposits with special guarantee (DPGE)	58,998	-	-	-	-	CDI+0.43% p.a.	58,998	CDI+0.49% p.a.	54,807
      Fixed income securities -government securities	16,940,471	3,874,062	3,705,608	3,950,884	3,811,949		24,596,963		20,249,429
      Financial treasury bills	15,820,361	33,764	33,837	-	-	SELIC	15,854,198	SELIC	13,381,692
      National treasury bills Fixed rate	772,693	-	-	-	-	14.16% p.a.	772,693	13.43% p.a.	600,028
      National treasury notes Series F - Fixed rate	340	20,057	18,695	-	-	9.28% p.a.	19,035	9.27% p.a.	19,012
      Series B - Floating rate IPCA	38,525	3,482,961	3,324,653	75,507	64,219	IPCA+7.06% p.a.	3,438,685	IPCA+6.42% p.a.	1,903,885
      Series C - Floating rate IGP-M	79,928	337,280	328,423	1,789,456	1,661,809	IGPM+5.94% p.a.	2,197,807	IGPM+5.94% p.a.	2,164,767
      Fixed income securities abroad	228,624	-	-	2,085,921	2,085,921	13.87% p.a.	2,314,545	13.86% p.a.	2,180,045
      Variable income securities	223,500						223,500		227,711
      Shares	223,500	-	-	-	-	-	223,500	-	227,711
      Investment fund shares Fixed income, equity and multi-	4,224,281						4,224,281		3,949,500
      market investment fund shares	4,197,660	-	-	-	-	-	4,197,660	-	3,922,215
      Equity investment fund shares	26,621	-	-	-	-	-	26,621	-	27,285
      Other investments	11,105	-	-	-	-	- 11,105		- 3,820
      						44,849,667		38,630,179
      						Current 40,305,218 Noncurrent 4,544,449		Current 36,855,083 Noncurrent 1,775,096

      (a) For securities classified as at fair value through profit or loss (FVTPL), average market rates are used. For those classified as at fair value through other

      comprehensive income (FVOCI) and at amortized cost, acquisition rates (yield curve) are used for interest accrual purposes, while assets classified as FVOCI are also marked to market for fair value measurement purposes.

      Notes to the interim financial information June 30, 2026

      (In thousands of reais, unless otherwise stated)

3. Accounts receivable

   Individual Consolidated

   Description Note 06/30/2026 12/31/2025 06/30/2026 12/31/2025

   Accounts receivable - hospital services	5.1	5,256,685	5,312,008	8,716,328	8,689,373
   Other accounts receivable	5.2	-	-	3,353,298	3,212,746

   5,256,685 5,312,008 12,069,626 11,902,119

   Current	5,256,685	5,312,008	10,297,089 10,167,395
   Noncurrent	-	-	1,772,537 1,734,724

   1. Hospital services

      Trade accounts receivable comprise receivables from healthcare companies and individuals, as follows:

      Individual Consolidated

      	06/30/2026	12/31/2025	06/30/2026	12/31/2025
      Accounts receivable from health insurance and health plans	6,292,390	6,282,646	10,262,993	10,236,070
      Accounts receivable from individuals Allowance for expected credit losses and provision	81,352	116,415	177,854	213,927
      for disallowances (1,117,057)		(1,087,053)	(1,724,519)	(1,760,624)
      5,256,685		5,312,008	8,716,328	8,689,373

      Changes in provision for disallowances and allowance for expected credit losses

      Individual Consolidated

      06/30/2026 06/30/2025 06/30/2026 06/30/2025

      Balance at beginning of period	(1,087,053)	(1,114,970)	(1,760,624)	(1,873,401)
      (Set up)/Reversal of provision for disallowances
      and allowance for expected credit losses	(418,259)	(360,286)	(800,353)	(653,861)
      Write-offs (a)	373,801	350,016	836,458	659,906
      Provision arising from the transfer of assets (b)	14,454	16,533	-	-
      Transfer to assets available for sale	-	-	-	49,428

      Balance at end of period (1,117,057) (1,108,707) (1,724,519) (1,817,928)

      1. Write-offs include the derecognition of uncollectible amounts and elimination of accepted claim denials of the Group companies.

      2. Transfer of assets of Hospital Maternidade São Luiz Star and Hospital São Luiz Campinas, respectively.

Notes to the interim financial information June 30, 2026

(In thousands of reais, unless otherwise stated)

1. Accounts receivable (Continued)
   1. Hospital services (Continued)

At June 30, 2026 and December 31, 2025, the aging list of trade accounts receivable was as follows:

1 - 31 -

Individual

61 -

Overdue 91 -

121 -

181 -

360 -

Total Falling due 30 days 60 days 90 days 120 days 180 days 360 days 720 days

1 - 31 -

Consolidated

61 -

Overdue 91 -

121 -

181 -

360 -

Total Falling due 30 days 60 days 90 days 120 days 180 days 360 days 720 days

The Company's revenues arise from the provision of hospital services, including the use of medicines and hospital materials. Revenue is recognized to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured, i.e. upon rendering of medical services at an amount that reflects the consideration to which an entity expects to be entitled in exchange for providing services to a customer.

Changes in provision for disallowances and allowance for expected credit losses

The provision for disallowances and allowance for expected credit losses are presented reducing the balance of accounts receivable and recognized at an amount deemed sufficient by management to cover any expected losses on the realization of amounts billed.

The Company's criterion to recognize a provision for disallowances is to annually analyze the performance of notes overdue between 360 to 720 days, a period deemed sufficient for exhausting the collection process. The percentage reached is applied to the gross revenue recorded and recognized as a provision in current profit or loss, reflecting management's best expectation based on the analyzed history. The analysis is made individually by cash-generating unit, as well as the percentage recorded as a provision for disallowances in the year.

As a criterion for the recognition of an allowance for expected credit losses, an individual analysis of receivables is performed to identify specific counterparty risks. If necessary, an allowance for expected credit losses is recorded for the partial or total balance of receivables outstanding of these customers.

Notes to the interim financial information June 30, 2026

(In thousands of reais, unless otherwise stated)

1. Accounts receivable (Continued)

   5.2.	Other accounts receivable Consolidated
   Description	Note	06/30/2026	12/31/2025
   Other operating receivables	521	2,183,707	1,996,059
   Consideration receivable - ASO health plans	522	1,020,591	1,067,960
   Other (a)		149,000	148,727
   		3,353,298	3,212,746
   Current		1,580,761	1,478,022
   Noncurrent		1,772,537	1,734,724

   1. This balance is represented mainly by receivables related to securities obligations and receivables not directly related to insurance operations, in subsidiaries that operate in this industry.

Administrative service only (ASO) health plans are plans in which the Company administers medical and hospital expenses on behalf of its customers, and is fully reimbursed by the customers, recording only its administration fee as revenue. The amounts related to consideration receivable by maturity are as follows:

Consolidated

1. Inventories

   Individual Consolidated

   	06/30/2026	12/31/2025	06/30/2026	12/31/2025
   Medicines	150,172	154,193	353,070	353,373
   Special materials	141,076	141,241	306,637	293,537
   Disposable materials	133,264	119,507	280,929	298,194
   Consumables	38,705	42,654	93,808	93,786
   Laboratory materials	9,971	10,022	36,972	39,570
   Surgical sutures	8,699	9,176	16,693	18,065
   Dressing room materials	5,001	5,035	15,593	14,923
   Food stuff	6,066	6,817	11,554	12,431
   Other	48,221	39,133	101,072	72,231
   	541,175	527,778	1,216,328	1,196,110

   Notes to the interim financial information June 30, 2026

   (In thousands of reais, unless otherwise stated)

2. Transactions with related parties

   Significant related-party transactions

   The nature of significant related-party transactions is summarized below:

   1. Leases - the Company leases properties owned by the controlling shareholders, namely: properties of the hospitals Copa D'Or and Quinta D'Or, and the property of the administrative unit. Leases are at market value and generated an expense in P&L for the period ended June 30, 2026 of R$19,172 (R$14,355 at June 30, 2025), referring to interest and amortization of rights of use. Leases are annually restated by reference to the Extended Consumer Price Index (IPCA).

   2. Trans fers of funds between companies - to enhance the operations of certain investees and provide funds for expansion and/or acquisitions, management transfers funds between Group companies under current account remittance agreements entered into between the parties. These balances are substantially eliminated in the consolidated financial statements.

   3. Shared services - these are centralized services rendered by the parent company, Rede D'Or, such as legal assistance, marketing, accounting, treasury, accounts payable and accounts receivable, which are shared among the other entities of the Group based on apportionment criteria that take into consideration the contribution of each entity to the consolidated gross revenue.

   4. Debentures - certain subsidiaries issued nonconvertible debentures, which were acquired by the parent company. These debentures are intended to provide funds to the investees for investment in operations and expansion.

   5. Book-entry commercial papers- certain subsidiaries carried out a private placement of book-entry nonconvertible commercial papers, in specific cases, convertible into equity interests, with all of these commercial papers being acquired by the parent company. These commercial papers are intended to provide funds to the investees for investment in operations and expansion.

   6. Revenues and accounts receivable partially arise from commercial transactions conducted in the ordinary course of business relating to medical care provided to members of Sul América plans. These transactions have reference tables by type of service provided by the Company with Sul América and the maturities of these services are stipulated in a contract entered into between the parties.

Notes to the interim financial information June 30, 2026

(In thousands of reais, unless otherwise stated)

In addition to the balances presented in the tables below, the Parent Company and subsidiary Rede D'Or Finance carried out four debenture issue and purchase transactions: i) on January 17, 2018, subsidiary Rede D'Or Finance issued senior notes totaling US$500 thousand, and at the same time, the Parent Company issued debentures (10th issue), which were partially acquired by other investors and by subsidiary Rede D'Or Finance (Note 13); and ii) on January 22, 2020, subsidiary Rede D'Or Finance carried out the second issue of senior notes, in the total amount of US$850 thousand. On February 13, 2020, Rede D'Or Finance reopened the second issue of senior notes and issued an additional US$350 thousand in notes with the same characteristics as the initial issue. In addition, on April 17, 2020, the Parent Company issued debentures (17th issue - 1st series), which were acquired by subsidiary Rede D'Or Finance; and iii) on September 9, 2025, subsidiary Rede D'Or Finance carried out its third issue of senior notes, for a total amount of US$500 thousand. In addition, on September 30, 2025, the Parent Company issued debentures (37th issue), which were acquired by subsidiary Rede D'Or Finance. The respective debentures were offered through placement efforts abroad, in accordance with the applicable legislation; and iv) on April 28, 2026, subsidiary Rede D'Or Finance completed its fourth issue of senior notes, in the total amount of US$500 thousand. In addition, on May 26, 2026, the Parent Company issued debentures (40th issue), which were acquired by subsidiary Rede D'Or Finance. The respective debentures were issued through private placement efforts abroad, in compliance with applicable law.

Balances with related parties

Individual

1. Transactions with related parties (Continued)

   Consolidated

   		06/30/2026			12/31/2025			06/30/2025
   Company	Noncurrent assets	Noncurrent liabilities	P&L	Noncurrent assets	Current liabilities	Noncurrent liabilities	P&L	P&L
   Debentures Biocor (d)	-	-	(313)	-	16,860	-	(2,629)	(1,149)
   Shared services J. Badim S.A.	26,970	-	1,471	25,786	-	-	2,917	1,757
   New Surgical Materiais Cirúrgicos (a) JMJB Diagnósticos e Serviços Hospitalares S.A.	- 11,112	- -	- -	21,523 10,609	- -	- -	- -	- -
   J Badim S.A. (a)	8,638	-	-	8,221	-	-	-	-
   JM&AM Empreendimentos Imobiliários S.A. (b)	-	-	19,172	370	-	-	31,294	14,355
   Other	10,246	7,944	-	7,645	-	4,337	164	104
   	56,966	7,944	20,330	74,154	16,860	4,337	31,746	15,067

   1. Transfers of funds for acquisition of companies, properties, expansion of operations, among others. These balances are substantially eliminated in the consolidated financial statements.

   2. Lease of properties owned by the controlling shareholders of Rede D'Or.

   3. On December 18, 2025, Hospital Nossa Senhora das Neves conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$212,260, maturing on December 20, 2026. The debentures may be fully or partially

      subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On January 02, 2026, Hospital Nossa Senhora das Neves conducted the ninth private issue of nonconvertible, single-series, registered debentures in the amount of R$146,251, maturing on December 30, 2026. The debentures may be fully or partially

      subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 2.90% p.a. On March 16, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

   4. On December 19, 2023, Biocor conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$33,691, initially maturing on December 19, 2024; however, this term was extended to December 20, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.0% p.a. On June 23, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

      On October 10, 2025, Biocor conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$13,000, maturing on October 10, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. On June 23, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

      On February 06, 2026, Biocor conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$36,200, maturing on February 10, 2027. The debentures may be fully or partially s ubscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. On June 23, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

      On May 11, 2026, Biocor conducted the ninth private issue of nonconvertible, single-series, registered debentures in the amount of R$35,000, maturing on May 10, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or.

      Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. On June 23, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

   5. On December 29, 2023, Onco Star SP Oncologia Ltda. carried out a private placement of book-entry convertible commercial

      papers, without security interest or collateral security system, in a single series, of first issue, in the amount of R$1,082,544, maturing on December 29, 2030. The commercial papers may be fully or partially subscribed until the maturity date by Rede D'Or São Luiz. Commercial papers not subscribed after this period will be automatically canceled. The commercial papers earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.0% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees.

      On December 29, 2024, Onco Star SP Oncologia Ltda. carried out a private placement of book-entry convertible commercial papers, without security interest or collateral security system, in a single series, of second issue, in the amount of R$150,000, maturing on December 29, 2030. The commercial papers may be fully or partially subscribed until the maturity date by Rede D'Or São Luiz. Commercial papers not subscribed after this period will be automatically canceled. The commercial papers earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.0% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees.

      On March 31, 2026, Onco Star SP Oncologia Ltda. carried out the third private placement of book-entry convertible commercial papers, without security interest or collateral security system, in a single series, of third issue, in the amount of R$180,000, maturing on December 29, 2030. The commercial papers may be fully or partially subscribed until the maturity date by Rede D'Or. Commercial papers not subscribed after this period will be automatically canceled. The commercial papers earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.0% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees.

   6. On May 20, 2025, São Carlos conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$32,862, maturing on May 20, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On January 15, 2026, São Carlos conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$132,111, maturing on January 20, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On June 05, 2026, São Lucas conducted the ninth private issue of non-privileged, nonconvertible, single-series, registered debentures in the amount of R$159,000, maturing on June 10, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the variation of the DI (Interbank Deposit) rate plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

   7. On February 06, 2025, Norte D'Or conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$17,343, initially maturing on February 06, 2026; however, this term was extended to February 06, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. until April 10, 2025 and 10.03% p.a. from April 10, 2025. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On April 30, 2025, Norte D'Or conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$5,430, initially maturing on October 30, 2025; however, this term was extended to April 30, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 10.03% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

   8. On March 13, 2025, São Lucas conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$15,000, maturing on March 27, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On May 13, 2025, São Lucas conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$52,176, maturing on May 13, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On May 20, 2025, São Lucas conducted the ninth private issue of nonconvertible, single-series, registered debentures in the amount of R$142,403, maturing on May 20, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On July 20, 2025, São Lucas conducted the tenth private issue of nonconvertible, single-series, registered debentures in the amount of R$20,000, maturing on July 20, 2026; however, this term was extended to July 20, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On December 09, 2025, São Lucas conducted the eleventh private issue of nonconvertible, single-series, registered debentures in the amount of R$450,000, maturing on December 10, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a.

      Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

   9. On March 28, 2025, Proncor conducted the tenth private issue of nonconvertible, single-series, registered debentures in the amount of R$5,000, maturing on March 28, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On May 13, 2025, Proncor conducted the eleventh private issue of nonconvertible, single-series, registered debentures in the amount of R$22,690, maturing on May 13, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

      On July 24, 2025, Proncor conducted the twelfth private issue of nonconvertible, single-series, registered debentures in the amount of R$366,600, maturing on July 24, 2026; however, this term was extended to July 26, 2027. Up to June 30, 2026, subscriptions totaled R$255.671. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or.

      Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

   10. On April 17, 2025, Acreditar conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$181,000, initially maturing on April 17, 2026; however, this term was extended to April 20, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

   11. On April 17, 2025, Onco Dor Oncologia conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$235,000, maturing on April 20, 2028. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

   12. On April 18, 2025, Onco Dor BA Oncologia Ltda. (Cehon) carried out a private placement of book-entry nonconvertible commercial papers, without security interest or collateral security system, in a single series, of second issue, in the amount of R$75,800, maturing on April 20, 2027. The commercial papers may be fully or partially subscribed until the maturity date by Rede D'Or. Commercial papers not subscribed after this period will be automatically canceled. The commercial papers earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.0% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees.

   13. On August 10, 2025, Oncologia Rede D'Or S.A. conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$370,000, maturing on August 10, 2030. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn

       interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest is paid semiannually, and the face value will be paid on the maturity date. There are no guarantees for the debentures.

   14. On August 10, 2025, São Rafael conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$270,000, maturing on August 10, 2030. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.75% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

   15. On November 24, 2025, SulAmérica Companhia de Seguro Saúde conducted the second private issue of nonconvertible, single-series, registered debentures amounting to R$1,000,000, maturing on November 18, 2033. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.10% p.a. Interest is paid semiannually, and the face value will be paid on the maturity date. There are no guarantees for the debentures.

   16. On March 16, 2026, Mederi Distribuição e Importação de Produtos para a Saúde S.A. conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$208,500, maturing on March 20, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 2.90% p.a. Interest is paid semiannually, and the face value will be paid on the maturity date. There are no guarantees for the debentures.

       Key management personnel compensation

       The Company considers "Key management personnel" only the members of its Statutory Board and Board of Directors. At June 30, 2026 and 2025, key management personnel compensation is summarized as follows:

       06/30/2026		06/30/2025
       Salaries and bonuses	139,875	81,419
       Benefits	248	194
       Share-based payment	16,326	11,126
       	156,449	92,739

2. Investments

   Breakdown of and changes in investments - Individual

   Company 12/31/2025

   Equity

   accounting Dividends

   Capital increase/

   Future capital contribution

   Capital reduction / return of future capital

   contribution Trans fer Other 06/30/2026

   Medise Medicina Diagnóstico e Serviços S.A.	141,626	19,677	(41,747)	-	-	-	(2,263)	117,293
   Hospital Esperança S.A.	4,968,562	120,712	(98,084)	108,992	-	-	-	5,100,182
   PMJ Empreendimentos Imobiliários S.A. (a)	925,303	6,331	(24,471)	-	(10,443)	(269,572)	-	627,148
   Norte D'Or Participações S.A. (including goodwill)	132,474	7,683	-	47	-	-	-	140,204
   Onco D'Or Oncologia S.A.	297,402	103,138	-	-	-	-	(6,550)	393,990
   Jenner S.A. (including goodwill)	68,836	44,472	-	-	-	-	(8,168)	105,140
   JMJB Diagnósticos e Serviços Hospitalares	43,731	(2,612)	-	-	-	-	-	41,119
   Hospital Fluminense S.A. (including goodwill)	348,315	38,959	(45,239)	-	(80,282)	-	-	261,753
   Cardial Serviços Médicos (including goodwill)	177,515	37,294	(37,800)	-	-	-	1,310	178,319
   TJK Empreendimentos Hospitalares	17,953	956	(2,491)	-	-	-	-	16,418
   Santa Luzia II Empreendimentos Imobiliários Ltda.	60,114	(310)	-	-	(13,122)	-	-	46,682
   Clínica São Vicente (a)/(b)	4,208,667	102,919	(156,083)	203,203	-	(108,386)	750,675	5,000,995
   Rede D'or São Luiz Serviços Médicos S.A.	262,279	(23,060)	-	42,255	-	(5,612)	-	275,862
   Laboratórios Richet	379,059	(21,094)	-	67,194	-	-	9,514	434,673
   Qualicorp Consultoria e Corretora de Seguros S.A.	485,090	(891)	-	-	-	-	(299)	483,900
   Clínica Médica São Remo	66,817	(3,843)	-	7,117	-	-	-	70,091
   Hospital Santa Cruz	445,481	12,438	(6,337)	21,199	-	-	-	472,781
   Advance Plano de Saúde S.A.	31,323	(1,065)	-	-	-	-	-	30,258
   PrismaQuali Gestão Ativa de Participações S.A.	1,607,280	(2,697)	-	-	(4,657)	-	(1,322)	1,598,604
   RDSLGF Greenfields Ltda.	915,759	27,552	(460)	5,675	-	128,818	4,130	1,081,474
   RDSL OH Operações Hospitalares Ltda.	286,305	60,047	(5,040)	104,923	-	63,797	2,916	512,948
   Traditio Companhia de Seguros	5,862,361	607,251	-	-	-	-	57,012	6,526,624
   Cia Saúde - SulAmérica	5,245,987	733,541	-	-	-	-	69,523	6,049,051
   SAEPAR Serviços e Participações	2,547,373	264,240	-	-	-	-	22,123	2,833,736
   Other	1,942,636	(8,760)	(95,707)	88,489	(22,822)	(428)	8,607	1,912,015

   31,468,248 2,122,878 (513,459) 649,094 (131,326) (191,383) 907,208 34,311,260

   1. On January 30, 2026, the Company completed the contribution of the assets and liabilities of Hospital Glória D'Or and SPE IH Glória D'Or to Atlântica D'Or.

On June 17, 2026, Clínica São Vicente, through its wholly owned subsidiary Clínica São Lucas, acquired all shares held by the non-controlling shareholders, representing a 49% ownership interest in Biocor, for a purchas e price of R$129,200. As a result of this transaction, the Company exercised the call/put option previously recognized as a financial liability, which amounted to R$495,211 at the exercise date. Accordingly, the liability was fully derecognized, resulting in an effect of R$366,011, which was recognized as an equity transaction and recorded directly in the controlling shareholders' equity.In addition, the amount previously recognized as non-controlling interests in the consolidated financial statements, measured at fair value upon the acquisition of control, was added to the parent company's investment balance. Consequently, Clínica São Vicente recorded, within its investments, a movement in other reserves of R$691,597, with a corresponding entry to capital reserves, totaling R$750,675, recognized directly in equity, with no impact on profit or loss for the period and no change in consolidated goodwill.

Company 12/31/2025

Equity

accounting Dividends

Capital increas e/ Future capital

contribution Transfer 06/30/2026

Rede D'or Finance (166,598) 11,497 - - - (155,101)

(839,321) (65,985) - 30 - (905,276)

Equity method 2,056,893

ompany 12/31/2024

Equity

accounting Dividends

Capital increase/

Future capital contribution

Capital reduction / return of future

capital contribution

Transfers to assets held for

sale Transfer Other 06/30/2025

Company 12/31/2024 Equity accounting

Capital increas e/

Future capital contribution

Capital reduction / return of future

capital contribution Other 06/30/2025

Rede D'or Finance (158,713) (19,704) - - - (178,417)

(719,421) (108,155) 3 (4,582) (10,709) (842,864)

Equity method 1,835,171

1. Investments (Continued)

   Breakdown of and changes in investments - Consolidated

   Company 12/31/2025

   Equity

   accounting Dividends

   Capital increas e/ Future capital

   contribution Other 06/30/2026

   JMJB Diagnósticos e Serviços Hospitalares S.A.	43,731	(2,612)	-	-	-	41,119
   Instituto de Radioterapia do Vale do Paraíba Ltda.	17,194	345	-	-	(172)	17,367
   Qualicorp Consultoria e Corretora de Seguros S.A. (a)	2,089,212	(3,837)	-	-	(1,288)	2,084,087
   Eldorado do Sul Participações Ltda.	10,707	3,706	(1,955)	-	(681)	11,777
   Other	277,020	15,626	(8,195)	24,054	651	309,156
   	2,437,864	13,228	(10,150)	24,054	(1,490)	2,463,506
   		Equity
   Company	12/31/2024	accounting	Dividends	Other	Transfer	06/30/2025
   JMJB Diagnósticos e Serviços Hospitalares S.A.	44,811	(2,224)	-	-	-	42,587
   Instituto de Radioterapia do Vale do Paraíba Ltda.	16,686	263	-	(141)	-	16,808
   Qualicorp Consultoria e Corretora de Seguros S.A. (a)	2,087,272	(5,252)	(404)	732	-	2,082,348
   Eldorado do Sul Participações Ltda.	35,791	3,670	-	(47)	-	39,414
   Other	298,996	16,041	(10,154)	-	(17,471)	287,412
   	2,483,556	12,498	(10,558)	544	(17,471)	2,468,569

   1. Based on the shareholders' agreement entered into in November 2019, considering the nominations to the Executive Board and Board of Directors that the Company is entitled to, it was concluded that Rede D'Or has significant influence over Qualicorp; therefore, it records the investment using the equity method. The Company recognized the equity accounting through December 31, 2026, in accordance with IAS 28 (CPC 18) - Investments in Associates and Joint Ventures.

Summary of information on main subsidiaries

06/30/2026 06/30/2025

Operating